Medicare Enrolled
Dr. Avinash Vallurupalli, DO
Internal Medicine · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vallurupalli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vallurupalli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vallurupalli
Dr. Avinash Vallurupalli is an internal medicine specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vallurupalli performed 2,167 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Vallurupalli received a total of $3,653 from 35 pharmaceutical and/or device companies across 149 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vallurupalli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 17% volume in TX
$3,653 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,167
Medicare services
Top 17% in TX for internal medicine
Not available
Unique patients (not deduplicated)
$175
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
336 | $281 | $700 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
279 | $93 | $400 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
178 | $60 | $300 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
170 | $0 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $70 | $300 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
97 | $39 | $250 |
| Injection, fentanyl citrate, 0.1 mg | 97 | $1 | $15 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
90 | $55 | $350 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
79 | $0 | $20 |
| Additional sedation, per 15 minutes Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period. |
74 | $8 | $50 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
69 | $51 | $300 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
63 | $235 | $600 |
| Ultrasound of hemodialysis access An ultrasound imaging test used to evaluate the blood flow and structure of a hemodialysis access site. |
63 | $101 | $700 |
| Ultrasound of blood vessel, initial vessel An ultrasound exam of a blood vessel that includes a radiologist's review of the initial vessel. |
62 | $759 | $2,500 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
50 | $97 | $400 |
| Hemodialysis circuit intervention with balloon dilation A procedure to insert a needle or tube into a hemodialysis circuit and dilate the dialysis segment using a balloon, with radiological review. |
48 | $951 | $5,100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
38 | $133 | $500 |
| Radiologist review of arm or leg artery image A radiologist reviews images of the arteries in the arm or leg. This process involves analyzing the visual data to assess the blood vessels. |
26 | $114 | $700 |
| Arterial catheter insertion, first order branch Placement of a catheter into a primary branch of an artery in the chest or arm. |
25 | $411 | $4,100 |
| Cefazolin sodium injection, 500 mg An injection of 500 mg of cefazolin sodium, an antibiotic medication, administered into the body. |
24 | $1 | $5 |
| Needle or tube insertion into hemodialysis circuit with radiologist review A procedure involving the insertion of a needle or tube into a hemodialysis circuit, accompanied by a review of the procedure by a radiologist. |
20 | $546 | $2,500 |
| Balloon dilation of dialysis access with radiologist review A minimally invasive procedure to widen a narrowed section of a dialysis access vessel using a balloon catheter. The procedure includes review by a radiologist to ensure proper placement and effectiveness. |
20 | $468 | $3,100 |
| Additional blood vessel ultrasound evaluation An ultrasound exam of a blood vessel that includes a radiologist's review. This code applies to each additional vessel evaluated beyond the initial one. |
20 | $134 | $900 |
| Contrast injection for X-ray imaging Administration of a contrast agent into a vein in the arm or leg to enhance visibility during an X-ray imaging procedure. |
18 | $232 | $1,400 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
18 | $75 | $350 |
| Hemodialysis circuit intervention with stent placement A radiologist inserts a needle or tube into the hemodialysis circuit and places a stent in the dialysis segment while reviewing the procedure. |
16 | $3,389 | $23,000 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 15 | $89 | $600 |
| Removal of tunneled central venous tube This procedure involves the removal of a catheter that has been surgically placed under the skin and threaded into a large vein. |
14 | $88 | $700 |
| Radiologist review of major upper body vein image A radiologist reviews images of the major veins in the upper body to assess their structure and function. |
14 | $81 | $600 |
| Pre-op ultrasound of artery and vein blood flow for hemodialysis access An ultrasound exam to assess blood flow in the arteries and veins on both sides of the body before surgery for hemodialysis access. |
14 | $191 | $800 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
14 | $47 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.5% high complexity
51.9% medium
45.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,653
Total received (2018-2024)
Avg $522/year across 7 years
Top 21% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
149
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$541
2023
$626
2022
$931
2021
$438
2020
$104
2019
$497
2018
$517
Payments by company (2024)
Amgen Inc.
$135
AstraZeneca Pharmaceuticals LP
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Bayer Healthcare Pharmaceuticals Inc.
$45
Mallinckrodt Hospital Products Inc.
$31
Travere Therapeutics, Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$25
Otsuka America Pharmaceutical, Inc.
$25
Aurinia Pharma U.S., Inc.
$25
AKEBIA THERAPEUTICS INC
$25
Philips North America LLC
$23
Vifor Pharma, Inc.
$22
Alexion Pharmaceuticals, Inc.
$19
Novartis Pharmaceuticals Corporation
$18
Boston Scientific Corporation
$17
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$601
AstraZeneca Pharmaceuticals LP
$352
Amgen Inc.
$342
Vifor Pharma, Inc.
$272
Bayer HealthCare Pharmaceuticals Inc.
$252
Medtronic Vascular, Inc.
$210
Veloxis Pharmaceuticals, Inc.
$158
Relypsa, Inc.
$135
Otsuka America Pharmaceutical, Inc.
$132
Bayer Healthcare Pharmaceuticals Inc.
$127
Keryx Biopharmaceuticals, Inc.
$121
BAXTER HEALTHCARE
$107
Fresenius USA Marketing, Inc.
$99
Travere Therapeutics, Inc.
$77
Bard Peripheral Vascular, Inc.
$74
Aurinia Pharma U.S., Inc.
$60
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
Alexion Pharmaceuticals, Inc.
$42
Boston Scientific Corporation
$42
Cook Medical LLC
$40
Ultragenyx Pharmaceutical Inc.
$37
AKEBIA THERAPEUTICS INC
$36
Philips Electronics North America Corporation
$31
Mallinckrodt Hospital Products Inc.
$31
GlaxoSmithKline, LLC.
$28
Philips North America LLC
$23
CALLIDITAS THERAPEUTICS US INC.
$22
W. L. Gore & Associates, Inc.
$18
Novartis Pharmaceuticals Corporation
$18
Novo Nordisk Inc
$16
OPKO Pharmaceuticals, LLC
$15
Cardiovascular Systems Inc.
$15
Arrow International, Inc.
$12
Tactile Systems Technology Inc
$11
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
(9260) QC · (BR5) Peripheral IVUS · ACTHAR · AMPLATZ · Auryxia · BENLYSTA · CROSSER · CRYSVITA · Catheter - Turnpike · ClosureFast · Cook Medical Stents · Cryvista · Dialyzers · ENVARSUS · Envarsus · FARXIGA · FLEXITOUCH · GATTEX · IGT D Peripheral · IN.PACT Admiral · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LIVTENCITY · LOKELMA · LUPKYNIS · Parsabiv · Peripheral Orbital Atherectomy System · RAYALDEE · Renal - Non Product Related · Rybelsus · SAMSCA · TARPEYO · TAVNEOS · TORNADO · Tavneos · ULTOMIRIS · Ultomiris · VIABAHN Endoprosthesis · Vafseo · Varithena Administration Pack · Velphoro · Veltassa · VenaSeal
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
905
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vallurupalli is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vallurupalli experienced with dialysis services for patients 20 or older?
Based on Medicare claims data, Dr. Vallurupalli performed 336 dialysis services for patients 20 or older services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Vallurupalli receive payments from pharmaceutical companies?
Yes. Dr. Vallurupalli received a total of $3,653 from 35 companies across 149 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vallurupalli's costs compare to other internal medicine physicians in Fort Worth?
Dr. Vallurupalli's average Medicare payment per service is $175. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vallurupalli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Fort Worth
Browse internal medicine physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology